A Feasibility study of alternate-day administrations of TS-1 as previously treated advanced non-small cell lung cancer in elderly patients
Phase 2
- Conditions
- Previously treated non-small cell lung cancer
- Registration Number
- JPRN-UMIN000011795
- Lead Sponsor
- Hiroshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1) Interstitial pneumonia or pulmonary fibrosis detectable on X ray. 2) Massive pleural or pericardial effusion,ascites 3) History of active double cancer within 5 years prior to the study. 4) Patients having active other cancers. 5) Ileus, Interstitial 6) Uncontrolled diabetes mellitus 7) Cardiac infarction or unstable angina within 6 months 8) Symptomatic brain metastases 9) Concomitant therapy with flucytocine, phenytoin or Warfarin Potassium 10) Serious psychiatric illness 11) History of severe hypersensitivity(>=Grade3) 12) History of using 5-FU o 13) Patient who is not candidates for TS-1 14) HBV-positive patients 15) Evaluated to be ineligible by a physician for other reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety
- Secondary Outcome Measures
Name Time Method 1yr OS,PFS,DCR